Table 1.
Features of trials appropriate for clinically-integrated versus more traditional randomized trials.
Clinically-integrated randomized trial | Traditional randomized trial | |
Tests, procedures, questionnaires | All data needed to address the study question would be of value for the clinician during routine follow-up. All tests, procedures and questionnaires would be given to patients irrespective of participation. Example: A test for cancer recurrence. |
Some data required to answer study-specific questions would not be taken during routine care. Example: blood draw for a molecular marker thought to predict response to treatment. |
Treatments | Patients very unlikely to have strong preferences for one or other treatment. Example: Two alternative suturing techniques during surgery. |
Many patients may have a strong preference for one or other treatment. Example: Radical versus breast conserving surgery. |
Comparisons | Can only compare two active treatments. Example: Two widely used anti-depressants of proven value. |
May compare an active treatment to placebo or no treatment control. Example: Novel anti-depressant versus placebo. |
Patients | Most patients are randomized. | Only a proportion of patients are randomized. |
Eligibility criteria | Eligibility criteria should be minimized. Example: all patients undergoing radical prostatectomy are eligible. |
Eligibility criteria can be restrictive. Example: restrictions on comorbidities in a trial of a novel drug. |
Information technology | Trial depends heavily on information technology. | Trial can be lo-tech. |